NetForum uses cookies to ensure that we give you the best experience on our website. If you continue to use the site, we'll assume that you are happy to receive these cookies on the NetForum website. Read about our cookies.
NetForum Community
Learn. Share. Optimize.
Log in | Sign up now | Submit content | Contact

Attention valued NetForum members:

Due to evolving technology needs and global privacy regulations, we have made the hard decision to suspend the NetForum User Community platform on Friday, November 29, 2019.

After this date, the current NetForum can no longer be reached. Please click here for more information about this decision, what happens next and how to stay in touch with us about the future of the community.

Go to similar content

mDIXON TSE in pediatric total spine

Case Study
Miller, Jeffrey, M.D. Phoenix Children's Hospital • USA

Patient history

A  5-year-old already diagnosed with metastatic leukemia was referred for an MRI examination at Phoenix Children’s Hospital (Phoenix, AZ, USA).

MR examination

The examination was performed on Ingenia 3.0T using the dS Torso coil solution.
mDIXON TSE is compared to T1-weighted SPIR.

View ExamCard


Click on an image to enlarge.
Standard post T1 STIR Voxels 0.6 x 0.9 x 3 mm <br>
scan time 6:22 min <br>
<br>mDIXON TSE post T1 water only Voxels 0.6 x 0.9 x 3 mm <br>
scan time 5:52 min <br>
Standard post T1 STIR
mDIXON TSE post T1 water only
Voxels 0.6 x 0.9 x 3 mm
scan time 6:22 min

Voxels 0.6 x 0.9 x 3 mm
scan time 5:52 min

Both mDIXON TSE and T1-weighted SPIR demonstrate deposits within the vertebral bone marrow (box) and deposits coating the surface of the spinal cord and nerve roots (arrow).
All of the lesions seen on standard SPIR are also seen on mDIXON TSE.

Clinical impact

Evaluating many cases like this contributes to Dr. Miller's diagnostic confidence that mDIXON has equal sensitivity in visualizing these important lesions. With this confidence, we can therefore use mDIXON TSE instead of SPIR to benefit from the reliable fat suppression of mDIXON TSE without being concerned to miss abnormalities like these because of the changed method. 

Related reading:

Results from case studies are not predictive of results in other cases. Results in other cases may vary.

This content has been made possible by NetForum Community.
Share this on: Share your link in twitter Share your link in facebook Share your link on LinkedIn Print Rate this article: Log in to vote

Jan 13, 2015

Rate this:
Log in to vote

Case Study
Ingenia 3.0T
mDIXON TSE, metastatic leukemia, Musculoskeletal, Neuro, Oncology, Pediatric, Spine, Total spine

Clinical News
Best Practices
Case Studies
Publications and Abstracts
White Papers
Web seminars and Presentations
Application Tips and FAQ
Try an Application
Business News
Case Studies
White Papers
Web Seminars and Presentations
Utilization Services
Contributing Professionals
Contributing Institutions
Become a Contributor